The Trump administration’s plans to reduce National Institutes of Health grant funding could have long-term consequences for the U.S. drug industry, investors said.
Our decentralized system of research was designed to produce an ambitious, but uniquely American, way of doing science.
While some NIH study sections will resume, advisory council meetings, which make final funding decisions, seem to still be ...
How Trump’s policy changes to NIH’s ‘indirect costs’ would affect one Idaho research program
When will our congressional delegation stand up for hardworking Idahoans who are, right now, stepping into laboratories to ...
A family whose 6-year-old is battling cancer says a move to slash funding by the National Institutes of Health (NIH) for ...
Hosted on MSN3h
Rare disease meeting gets pushed off by HHSAs hundreds of researchers, patient advocates and policymakers gather in Washington, D.C., this week for an advocacy fly-in ...
A UC San Diego-led team's project to develop next-generation brain implants builds on the development of this transparent ...
The cutting-edge research that led to innovations from the early detection of Alzheimer’s disease to the development of the ...
College officials say the pause is necessary while they determine the impacts of the potential federal funding cuts.
OSU Professor Christina Dyar and her co-investigators received the five-year grant to fund the project titled “Bisexual ...
Spokane joined the ranks of others suing the Trump administration on Friday amid attempts to reduce federal spending after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback